P3 Health Partners Inc. (NASDAQ: PIIIW) Stock Competitors & Peer Comparison
See PIIIW's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for PIIIW and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| PIIIW | $0.01 | -28.46% | 14.9M | N/A | -$33.00 | N/A |
| HCA | $419.53 | +4.36% | 91.3B | 14.57 | $28.96 | +0.71% |
| THC | $264.38 | +2.05% | 21.7B | 15.61 | $17.24 | N/A |
| EHC | $120.71 | +0.20% | 12.1B | 20.82 | $5.84 | +0.63% |
| FMS | $22.33 | -0.53% | 12B | 8.39 | $2.66 | +3.87% |
| DVA | $182.00 | +1.08% | 11.7B | 14.30 | $12.80 | N/A |
| UHS | $171.97 | +0.04% | 10.6B | 7.80 | $22.54 | +0.45% |
| ENSG | $172.05 | +0.88% | 10B | 24.89 | $6.90 | +0.15% |
| OSH | $39.00 | +0.08% | 9.5B | -17.65 | -$2.21 | N/A |
| PACS | $44.49 | +1.87% | 7.1B | 23.59 | $1.89 | N/A |
Stock Comparison
HCA Healthcare, Inc. (NYSE: HCA)
PIIIW vs HCA Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, HCA has a market cap of 91.3B. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while HCA trades at $419.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas HCA's P/E ratio is 14.57. In terms of profitability, PIIIW's ROE is +1.61%, compared to HCA's ROE of -1.13%. Regarding short-term risk, PIIIW is more volatile compared to HCA. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check HCA's competition here
Tenet Healthcare Corporation (NYSE: THC)
PIIIW vs THC Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, THC has a market cap of 21.7B. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while THC trades at $264.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas THC's P/E ratio is 15.61. In terms of profitability, PIIIW's ROE is +1.61%, compared to THC's ROE of +0.51%. Regarding short-term risk, PIIIW is more volatile compared to THC. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check THC's competition here
Encompass Health Corporation (NYSE: EHC)
PIIIW vs EHC Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, EHC has a market cap of 12.1B. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while EHC trades at $120.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas EHC's P/E ratio is 20.82. In terms of profitability, PIIIW's ROE is +1.61%, compared to EHC's ROE of +0.25%. Regarding short-term risk, PIIIW is more volatile compared to EHC. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check EHC's competition here
Fresenius Medical Care AG & Co. KGaA (NYSE: FMS)
PIIIW vs FMS Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, FMS has a market cap of 12B. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while FMS trades at $22.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas FMS's P/E ratio is 8.39. In terms of profitability, PIIIW's ROE is +1.61%, compared to FMS's ROE of +0.07%. Regarding short-term risk, PIIIW is more volatile compared to FMS. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check FMS's competition here
DaVita Inc. (NYSE: DVA)
PIIIW vs DVA Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, DVA has a market cap of 11.7B. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while DVA trades at $182.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas DVA's P/E ratio is 14.30. In terms of profitability, PIIIW's ROE is +1.61%, compared to DVA's ROE of -1.24%. Regarding short-term risk, PIIIW is more volatile compared to DVA. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check DVA's competition here
Universal Health Services, Inc. (NYSE: UHS)
PIIIW vs UHS Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, UHS has a market cap of 10.6B. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while UHS trades at $171.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas UHS's P/E ratio is 7.80. In terms of profitability, PIIIW's ROE is +1.61%, compared to UHS's ROE of +0.21%. Regarding short-term risk, PIIIW is more volatile compared to UHS. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check UHS's competition here
The Ensign Group, Inc. (NASDAQ: ENSG)
PIIIW vs ENSG Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, ENSG has a market cap of 10B. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while ENSG trades at $172.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas ENSG's P/E ratio is 24.89. In terms of profitability, PIIIW's ROE is +1.61%, compared to ENSG's ROE of +0.17%. Regarding short-term risk, PIIIW is more volatile compared to ENSG. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check ENSG's competition here
Oak Street Health, Inc. (NYSE: OSH)
PIIIW vs OSH Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, OSH has a market cap of 9.5B. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while OSH trades at $39.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas OSH's P/E ratio is -17.65. In terms of profitability, PIIIW's ROE is +1.61%, compared to OSH's ROE of +4.64%. Regarding short-term risk, PIIIW is more volatile compared to OSH. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check OSH's competition here
PACS Group, Inc. (NYSE: PACS)
PIIIW vs PACS Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, PACS has a market cap of 7.1B. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while PACS trades at $44.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas PACS's P/E ratio is 23.59. In terms of profitability, PIIIW's ROE is +1.61%, compared to PACS's ROE of +0.27%. Regarding short-term risk, PIIIW is more volatile compared to PACS. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check PACS's competition here
Chemed Corporation (NYSE: CHE)
PIIIW vs CHE Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, CHE has a market cap of 6.8B. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while CHE trades at $510.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas CHE's P/E ratio is 24.00. In terms of profitability, PIIIW's ROE is +1.61%, compared to CHE's ROE of +0.29%. Regarding short-term risk, PIIIW is more volatile compared to CHE. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check CHE's competition here
Hims & Hers Health, Inc. (NYSE: HIMS)
PIIIW vs HIMS Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, HIMS has a market cap of 6.2B. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while HIMS trades at $27.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas HIMS's P/E ratio is -43.62. In terms of profitability, PIIIW's ROE is +1.61%, compared to HIMS's ROE of -0.30%. Regarding short-term risk, PIIIW is more volatile compared to HIMS. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check HIMS's competition here
LHC Group, Inc. (NASDAQ: LHCG)
PIIIW vs LHCG Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, LHCG has a market cap of 5.3B. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while LHCG trades at $169.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas LHCG's P/E ratio is 82.83. In terms of profitability, PIIIW's ROE is +1.61%, compared to LHCG's ROE of +0.04%. Regarding short-term risk, PIIIW is more volatile compared to LHCG. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check LHCG's competition here
LifeStance Health Group, Inc. (NASDAQ: LFST)
PIIIW vs LFST Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, LFST has a market cap of 4.9B. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while LFST trades at $13.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas LFST's P/E ratio is 95.05. In terms of profitability, PIIIW's ROE is +1.61%, compared to LFST's ROE of +0.03%. Regarding short-term risk, PIIIW is more volatile compared to LFST. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check LFST's competition here
Concentra Group Holdings Parent, Inc. (NYSE: CON)
PIIIW vs CON Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, CON has a market cap of 4.4B. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while CON trades at $34.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas CON's P/E ratio is 21.50. In terms of profitability, PIIIW's ROE is +1.61%, compared to CON's ROE of +0.47%. Regarding short-term risk, PIIIW is more volatile compared to CON. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check CON's competition here
National HealthCare Corporation (AMEX: NHC)
PIIIW vs NHC Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, NHC has a market cap of 3.6B. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while NHC trades at $224.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas NHC's P/E ratio is 29.09. In terms of profitability, PIIIW's ROE is +1.61%, compared to NHC's ROE of +0.13%. Regarding short-term risk, PIIIW is more volatile compared to NHC. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check NHC's competition here
Option Care Health, Inc. (NASDAQ: OPCH)
PIIIW vs OPCH Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, OPCH has a market cap of 3.5B. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while OPCH trades at $23.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas OPCH's P/E ratio is 13.74. In terms of profitability, PIIIW's ROE is +1.61%, compared to OPCH's ROE of +0.16%. Regarding short-term risk, PIIIW is more volatile compared to OPCH. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check OPCH's competition here
Amedisys, Inc. (NASDAQ: AMED)
PIIIW vs AMED Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, AMED has a market cap of 3.3B. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while AMED trades at $100.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas AMED's P/E ratio is 39.30. In terms of profitability, PIIIW's ROE is +1.61%, compared to AMED's ROE of +0.11%. Regarding short-term risk, PIIIW is more volatile compared to AMED. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check AMED's competition here
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH)
PIIIW vs AVAH Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, AVAH has a market cap of 3.1B. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while AVAH trades at $13.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas AVAH's P/E ratio is 20.62. In terms of profitability, PIIIW's ROE is +1.61%, compared to AVAH's ROE of +1.50%. Regarding short-term risk, PIIIW is more volatile compared to AVAH. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check AVAH's competition here
Brookdale Senior Living Inc. (NYSE: BKD)
PIIIW vs BKD Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, BKD has a market cap of 2.9B. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while BKD trades at $12.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas BKD's P/E ratio is -20.94. In terms of profitability, PIIIW's ROE is +1.61%, compared to BKD's ROE of +4.06%. Regarding short-term risk, PIIIW is more volatile compared to BKD. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check BKD's competition here
Guardian Pharmacy Services, Inc. (NYSE: GRDN)
PIIIW vs GRDN Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, GRDN has a market cap of 2.7B. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while GRDN trades at $42.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas GRDN's P/E ratio is 38.03. In terms of profitability, PIIIW's ROE is +1.61%, compared to GRDN's ROE of +0.31%. Regarding short-term risk, PIIIW is more volatile compared to GRDN. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check GRDN's competition here
Acadia Healthcare Company, Inc. (NASDAQ: ACHC)
PIIIW vs ACHC Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, ACHC has a market cap of 2.6B. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while ACHC trades at $28.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas ACHC's P/E ratio is 14.17. In terms of profitability, PIIIW's ROE is +1.61%, compared to ACHC's ROE of -0.50%. Regarding short-term risk, PIIIW is more volatile compared to ACHC. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check ACHC's competition here
Addus HomeCare Corporation (NASDAQ: ADUS)
PIIIW vs ADUS Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, ADUS has a market cap of 2.2B. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while ADUS trades at $117.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas ADUS's P/E ratio is 17.85. In terms of profitability, PIIIW's ROE is +1.61%, compared to ADUS's ROE of +0.10%. Regarding short-term risk, PIIIW is more volatile compared to ADUS. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check ADUS's competition here
Pediatrix Medical Group, Inc. (NYSE: MD)
PIIIW vs MD Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, MD has a market cap of 2.2B. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while MD trades at $27.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas MD's P/E ratio is 12.09. In terms of profitability, PIIIW's ROE is +1.61%, compared to MD's ROE of +0.20%. Regarding short-term risk, PIIIW is more volatile compared to MD. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check MD's competition here
Select Medical Holdings Corporation (NYSE: SEM)
PIIIW vs SEM Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, SEM has a market cap of 2B. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while SEM trades at $16.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas SEM's P/E ratio is 15.43. In terms of profitability, PIIIW's ROE is +1.61%, compared to SEM's ROE of +0.08%. Regarding short-term risk, PIIIW is more volatile compared to SEM. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check SEM's competition here
Astrana Health, Inc. (NASDAQ: ASTH)
PIIIW vs ASTH Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, ASTH has a market cap of 1.9B. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while ASTH trades at $38.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas ASTH's P/E ratio is 45.86. In terms of profitability, PIIIW's ROE is +1.61%, compared to ASTH's ROE of +0.05%. Regarding short-term risk, PIIIW is more volatile compared to ASTH. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check ASTH's competition here
Sonida Senior Living, Inc. (NYSE: SNDA)
PIIIW vs SNDA Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, SNDA has a market cap of 1.9B. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while SNDA trades at $39.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas SNDA's P/E ratio is -6.39. In terms of profitability, PIIIW's ROE is +1.61%, compared to SNDA's ROE of -0.26%. Regarding short-term risk, PIIIW is more volatile compared to SNDA. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check SNDA's competition here
Surgery Partners, Inc. (NASDAQ: SGRY)
PIIIW vs SGRY Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, SGRY has a market cap of 1.8B. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while SGRY trades at $14.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas SGRY's P/E ratio is 36.21. In terms of profitability, PIIIW's ROE is +1.61%, compared to SGRY's ROE of -0.05%. Regarding short-term risk, PIIIW is more volatile compared to SGRY. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check SGRY's competition here
Apollo Medical Holdings, Inc. (NASDAQ: AMEH)
PIIIW vs AMEH Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, AMEH has a market cap of 1.8B. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while AMEH trades at $40.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas AMEH's P/E ratio is 39.25. In terms of profitability, PIIIW's ROE is +1.61%, compared to AMEH's ROE of +0.05%. Regarding short-term risk, PIIIW is more volatile compared to AMEH. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check AMEH's competition here
Ardent Health Inc. (NYSE: ARDT)
PIIIW vs ARDT Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, ARDT has a market cap of 1.6B. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while ARDT trades at $10.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas ARDT's P/E ratio is 8.98. In terms of profitability, PIIIW's ROE is +1.61%, compared to ARDT's ROE of +0.05%. Regarding short-term risk, PIIIW is more volatile compared to ARDT. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check ARDT's competition here
Agilon Health, Inc. (NYSE: AGL)
PIIIW vs AGL Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, AGL has a market cap of 1.6B. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while AGL trades at $94.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas AGL's P/E ratio is -6.09. In terms of profitability, PIIIW's ROE is +1.61%, compared to AGL's ROE of -1.19%. Regarding short-term risk, PIIIW is more volatile compared to AGL. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check AGL's competition here
Healthcare Services Group, Inc. (NASDAQ: HCSG)
PIIIW vs HCSG Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, HCSG has a market cap of 1.5B. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while HCSG trades at $21.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas HCSG's P/E ratio is 17.62. In terms of profitability, PIIIW's ROE is +1.61%, compared to HCSG's ROE of +0.24%. Regarding short-term risk, PIIIW is more volatile compared to HCSG. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check HCSG's competition here
Innovage Holding Corp. (NASDAQ: INNV)
PIIIW vs INNV Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, INNV has a market cap of 1.5B. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while INNV trades at $10.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas INNV's P/E ratio is -122.56. In terms of profitability, PIIIW's ROE is +1.61%, compared to INNV's ROE of -0.01%. Regarding short-term risk, PIIIW is more volatile compared to INNV. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check INNV's competition here
The Pennant Group, Inc. (NASDAQ: PNTG)
PIIIW vs PNTG Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, PNTG has a market cap of 1.4B. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while PNTG trades at $39.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas PNTG's P/E ratio is 30.00. In terms of profitability, PIIIW's ROE is +1.61%, compared to PNTG's ROE of +0.10%. Regarding short-term risk, PIIIW is more volatile compared to PNTG. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check PNTG's competition here
Nutex Health, Inc. (NASDAQ: NUTX)
PIIIW vs NUTX Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, NUTX has a market cap of 1.4B. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while NUTX trades at $196.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas NUTX's P/E ratio is 7.82. In terms of profitability, PIIIW's ROE is +1.61%, compared to NUTX's ROE of +0.52%. Regarding short-term risk, PIIIW is more volatile compared to NUTX. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check NUTX's competition here
AMN Healthcare Services, Inc. (NYSE: AMN)
PIIIW vs AMN Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, AMN has a market cap of 1.3B. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while AMN trades at $33.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas AMN's P/E ratio is 11.41. In terms of profitability, PIIIW's ROE is +1.61%, compared to AMN's ROE of +0.15%. Regarding short-term risk, PIIIW is more volatile compared to AMN. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check AMN's competition here
Brookdale Senior Living Inc. 7. (NYSE: BKDT)
PIIIW vs BKDT Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, BKDT has a market cap of 1.2B. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while BKDT trades at $77.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas BKDT's P/E ratio is N/A. In terms of profitability, PIIIW's ROE is +1.61%, compared to BKDT's ROE of +4.06%. Regarding short-term risk, PIIIW is more volatile compared to BKDT. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check BKDT's competition here
U.S. Physical Therapy, Inc. (NYSE: USPH)
PIIIW vs USPH Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, USPH has a market cap of 1.2B. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while USPH trades at $77.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas USPH's P/E ratio is 30.60. In terms of profitability, PIIIW's ROE is +1.61%, compared to USPH's ROE of -0.01%. Regarding short-term risk, PIIIW is more volatile compared to USPH. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check USPH's competition here
Talkspace, Inc. (NASDAQ: TALK)
PIIIW vs TALK Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, TALK has a market cap of 879.4M. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while TALK trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas TALK's P/E ratio is 774.34. In terms of profitability, PIIIW's ROE is +1.61%, compared to TALK's ROE of +0.00%. Regarding short-term risk, PIIIW is more volatile compared to TALK. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check TALK's competition here
GMR Solutions Inc. (NYSE: GMRS)
PIIIW vs GMRS Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, GMRS has a market cap of 707.8M. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while GMRS trades at $12.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas GMRS's P/E ratio is 5.82. In terms of profitability, PIIIW's ROE is +1.61%, compared to GMRS's ROE of +0.16%. Regarding short-term risk, PIIIW is more volatile compared to GMRS. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check GMRS's competition here
Enhabit, Inc. (NYSE: EHAB)
PIIIW vs EHAB Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, EHAB has a market cap of 706.9M. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while EHAB trades at $13.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas EHAB's P/E ratio is -197.14. In terms of profitability, PIIIW's ROE is +1.61%, compared to EHAB's ROE of -0.01%. Regarding short-term risk, PIIIW is more volatile compared to EHAB. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check EHAB's competition here
Starling Oncology, Inc. (NASDAQ: STLN)
PIIIW vs STLN Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, STLN has a market cap of 628.9M. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while STLN trades at $6.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas STLN's P/E ratio is N/A. In terms of profitability, PIIIW's ROE is +1.61%, compared to STLN's ROE of +2.10%. Regarding short-term risk, PIIIW is more volatile compared to STLN. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check STLN's competition here
The Oncology Institute, Inc. (NASDAQ: TOI)
PIIIW vs TOI Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, TOI has a market cap of 512.9M. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while TOI trades at $5.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas TOI's P/E ratio is -14.25. In terms of profitability, PIIIW's ROE is +1.61%, compared to TOI's ROE of +2.10%. Regarding short-term risk, PIIIW is more volatile compared to TOI. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check TOI's competition here
Strata Critical Medical, Inc. (NASDAQ: SRTA)
PIIIW vs SRTA Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, SRTA has a market cap of 451.7M. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while SRTA trades at $5.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas SRTA's P/E ratio is -24.61. In terms of profitability, PIIIW's ROE is +1.61%, compared to SRTA's ROE of +0.14%. Regarding short-term risk, PIIIW is more volatile compared to SRTA. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check SRTA's competition here
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA)
PIIIW vs MCTA Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, MCTA has a market cap of 445.6M. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while MCTA trades at $29.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas MCTA's P/E ratio is 419.36. In terms of profitability, PIIIW's ROE is +1.61%, compared to MCTA's ROE of -2.33%. Regarding short-term risk, PIIIW is more volatile compared to MCTA. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check MCTA's competition here
Community Health Systems, Inc. (NYSE: CYH)
PIIIW vs CYH Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, CYH has a market cap of 414.6M. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while CYH trades at $2.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas CYH's P/E ratio is 4.03. In terms of profitability, PIIIW's ROE is +1.61%, compared to CYH's ROE of +0.21%. Regarding short-term risk, PIIIW is more volatile compared to CYH. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check CYH's competition here
Auna S.A. (NYSE: AUNA)
PIIIW vs AUNA Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, AUNA has a market cap of 384.2M. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while AUNA trades at $5.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas AUNA's P/E ratio is 4.68. In terms of profitability, PIIIW's ROE is +1.61%, compared to AUNA's ROE of +0.01%. Regarding short-term risk, PIIIW is more volatile compared to AUNA. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check AUNA's competition here
Viemed Healthcare, Inc. (NASDAQ: VMD)
PIIIW vs VMD Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, VMD has a market cap of 333.7M. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while VMD trades at $8.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas VMD's P/E ratio is 24.33. In terms of profitability, PIIIW's ROE is +1.61%, compared to VMD's ROE of +0.10%. Regarding short-term risk, PIIIW is more volatile compared to VMD. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check VMD's competition here
Capital Senior Living Corporation (NYSE: CSU)
PIIIW vs CSU Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, CSU has a market cap of 223.7M. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while CSU trades at $33.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas CSU's P/E ratio is 0.67. In terms of profitability, PIIIW's ROE is +1.61%, compared to CSU's ROE of -0.33%. Regarding short-term risk, PIIIW is more volatile compared to CSU. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check CSU's competition here
AirSculpt Technologies, Inc. (NASDAQ: AIRS)
PIIIW vs AIRS Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, AIRS has a market cap of 184.1M. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while AIRS trades at $2.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas AIRS's P/E ratio is -87.00. In terms of profitability, PIIIW's ROE is +1.61%, compared to AIRS's ROE of -0.13%. Regarding short-term risk, PIIIW is more volatile compared to AIRS. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check AIRS's competition here
The Joint Corp. (NASDAQ: JYNT)
PIIIW vs JYNT Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, JYNT has a market cap of 115.3M. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while JYNT trades at $8.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas JYNT's P/E ratio is 80.90. In terms of profitability, PIIIW's ROE is +1.61%, compared to JYNT's ROE of +0.22%. Regarding short-term risk, PIIIW is more volatile compared to JYNT. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check JYNT's competition here
Five Star Senior Living Inc. (NASDAQ: FVE)
PIIIW vs FVE Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, FVE has a market cap of 98.4M. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while FVE trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas FVE's P/E ratio is -5.64. In terms of profitability, PIIIW's ROE is +1.61%, compared to FVE's ROE of -0.15%. Regarding short-term risk, PIIIW is more volatile compared to FVE. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check FVE's competition here
Kindly MD, Inc. (NASDAQ: KDLYW)
PIIIW vs KDLYW Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, KDLYW has a market cap of 96.5M. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while KDLYW trades at $18.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas KDLYW's P/E ratio is N/A. In terms of profitability, PIIIW's ROE is +1.61%, compared to KDLYW's ROE of -1.05%. Regarding short-term risk, PIIIW is less volatile compared to KDLYW. This indicates lower risk in terms of short-term price fluctuations for PIIIW.Check KDLYW's competition here
Park Dental Partners, Inc. Common Stock (NASDAQ: PARK)
PIIIW vs PARK Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, PARK has a market cap of 94.7M. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while PARK trades at $20.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas PARK's P/E ratio is 28.35. In terms of profitability, PIIIW's ROE is +1.61%, compared to PARK's ROE of -0.18%. Regarding short-term risk, PIIIW is more volatile compared to PARK. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check PARK's competition here
biote Corp. (NASDAQ: BTMD)
PIIIW vs BTMD Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, BTMD has a market cap of 64M. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while BTMD trades at $1.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas BTMD's P/E ratio is 13.18. In terms of profitability, PIIIW's ROE is +1.61%, compared to BTMD's ROE of -0.09%. Regarding short-term risk, PIIIW is more volatile compared to BTMD. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check BTMD's competition here
AlerisLife Inc. (NASDAQ: ALR)
PIIIW vs ALR Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, ALR has a market cap of 44.2M. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while ALR trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas ALR's P/E ratio is -1.11. In terms of profitability, PIIIW's ROE is +1.61%, compared to ALR's ROE of -0.15%. Regarding short-term risk, PIIIW is more volatile compared to ALR. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check ALR's competition here
DocGo Inc. (NASDAQ: DCGO)
PIIIW vs DCGO Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, DCGO has a market cap of 36.5M. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while DCGO trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas DCGO's P/E ratio is -0.20. In terms of profitability, PIIIW's ROE is +1.61%, compared to DCGO's ROE of -1.16%. Regarding short-term risk, PIIIW is more volatile compared to DCGO. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check DCGO's competition here
Cryo-Cell International, Inc. (AMEX: CCEL)
PIIIW vs CCEL Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, CCEL has a market cap of 33.1M. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while CCEL trades at $4.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas CCEL's P/E ratio is -13.70. In terms of profitability, PIIIW's ROE is +1.61%, compared to CCEL's ROE of +0.14%. Regarding short-term risk, PIIIW is more volatile compared to CCEL. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check CCEL's competition here
IMAC Holdings, Inc. (NASDAQ: IMAC)
PIIIW vs IMAC Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, IMAC has a market cap of 33.1M. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while IMAC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas IMAC's P/E ratio is -2.27. In terms of profitability, PIIIW's ROE is +1.61%, compared to IMAC's ROE of +0.00%. Regarding short-term risk, PIIIW is more volatile compared to IMAC. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check IMAC's competition here
P3 Health Partners Inc. (NASDAQ: PIII)
PIIIW vs PIII Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, PIII has a market cap of 28.2M. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while PIII trades at $8.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas PIII's P/E ratio is -0.26. In terms of profitability, PIIIW's ROE is +1.61%, compared to PIII's ROE of +1.61%. Regarding short-term risk, PIIIW is more volatile compared to PIII. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check PIII's competition here
EUDA Health Holdings Limited (NASDAQ: EUDA)
PIIIW vs EUDA Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, EUDA has a market cap of 24.5M. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while EUDA trades at $12.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas EUDA's P/E ratio is -24.74. In terms of profitability, PIIIW's ROE is +1.61%, compared to EUDA's ROE of +1.20%. Regarding short-term risk, PIIIW is more volatile compared to EUDA. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check EUDA's competition here
Cano Health, Inc. (NYSE: CANO-WT)
PIIIW vs CANO-WT Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, CANO-WT has a market cap of 19.3M. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while CANO-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas CANO-WT's P/E ratio is N/A. In terms of profitability, PIIIW's ROE is +1.61%, compared to CANO-WT's ROE of -1.49%. Regarding short-term risk, PIIIW is less volatile compared to CANO-WT. This indicates lower risk in terms of short-term price fluctuations for PIIIW.Check CANO-WT's competition here
Aesthetic Medical International Holdings Group Limited (NASDAQ: AIH)
PIIIW vs AIH Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, AIH has a market cap of 15.9M. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while AIH trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas AIH's P/E ratio is -2.78. In terms of profitability, PIIIW's ROE is +1.61%, compared to AIH's ROE of +1.16%. Regarding short-term risk, PIIIW is less volatile compared to AIH. This indicates lower risk in terms of short-term price fluctuations for PIIIW.Check AIH's competition here
Cano Health, Inc. (NYSE: CANO)
PIIIW vs CANO Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, CANO has a market cap of 12.4M. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while CANO trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas CANO's P/E ratio is -0.01. In terms of profitability, PIIIW's ROE is +1.61%, compared to CANO's ROE of -1.49%. Regarding short-term risk, PIIIW is more volatile compared to CANO. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check CANO's competition here
Avem Health Partners, Inc. (NYSE: FPCG)
PIIIW vs FPCG Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, FPCG has a market cap of 10.1M. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while FPCG trades at $1,025.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas FPCG's P/E ratio is 0.09. In terms of profitability, PIIIW's ROE is +1.61%, compared to FPCG's ROE of +0.00%. Regarding short-term risk, PIIIW is more volatile compared to FPCG. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check FPCG's competition here
American Shared Hospital Services (AMEX: AMS)
PIIIW vs AMS Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, AMS has a market cap of 9.9M. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while AMS trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas AMS's P/E ratio is -5.90. In terms of profitability, PIIIW's ROE is +1.61%, compared to AMS's ROE of -0.07%. Regarding short-term risk, PIIIW is more volatile compared to AMS. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check AMS's competition here
Field Trip Health Ltd. (NASDAQ: FTRP)
PIIIW vs FTRP Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, FTRP has a market cap of 9.8M. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while FTRP trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas FTRP's P/E ratio is -1.22. In terms of profitability, PIIIW's ROE is +1.61%, compared to FTRP's ROE of -0.62%. Regarding short-term risk, PIIIW is more volatile compared to FTRP. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check FTRP's competition here
Basel Medical Group Ltd Ordinary Shares (NASDAQ: BMGL)
PIIIW vs BMGL Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, BMGL has a market cap of 7.3M. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while BMGL trades at $4.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas BMGL's P/E ratio is -0.88. In terms of profitability, PIIIW's ROE is +1.61%, compared to BMGL's ROE of -1.74%. Regarding short-term risk, PIIIW is more volatile compared to BMGL. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check BMGL's competition here
20/20 Biolabs Inc. (NASDAQ: AIDX)
PIIIW vs AIDX Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, AIDX has a market cap of 6.9M. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while AIDX trades at $0.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas AIDX's P/E ratio is -1.06. In terms of profitability, PIIIW's ROE is +1.61%, compared to AIDX's ROE of -3.87%. Regarding short-term risk, PIIIW is more volatile compared to AIDX. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check AIDX's competition here
ModivCare Inc. (NASDAQ: MODV)
PIIIW vs MODV Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, MODV has a market cap of 6.2M. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while MODV trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas MODV's P/E ratio is -0.03. In terms of profitability, PIIIW's ROE is +1.61%, compared to MODV's ROE of +1.36%. Regarding short-term risk, PIIIW is more volatile compared to MODV. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check MODV's competition here
Greenbrook TMS Inc. (NASDAQ: GBNH)
PIIIW vs GBNH Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, GBNH has a market cap of 5.5M. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while GBNH trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas GBNH's P/E ratio is -0.06. In terms of profitability, PIIIW's ROE is +1.61%, compared to GBNH's ROE of +15.74%. Regarding short-term risk, PIIIW is less volatile compared to GBNH. This indicates lower risk in terms of short-term price fluctuations for PIIIW.Check GBNH's competition here
Regional Health Properties, Inc. (AMEX: RHE-PA)
PIIIW vs RHE-PA Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, RHE-PA has a market cap of 5.2M. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while RHE-PA trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, PIIIW's ROE is +1.61%, compared to RHE-PA's ROE of +1.09%. Regarding short-term risk, PIIIW is less volatile compared to RHE-PA. This indicates lower risk in terms of short-term price fluctuations for PIIIW.Check RHE-PA's competition here
Regional Health Properties, Inc. (AMEX: RHE)
PIIIW vs RHE Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, RHE has a market cap of 5.2M. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while RHE trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas RHE's P/E ratio is -1.79. In terms of profitability, PIIIW's ROE is +1.61%, compared to RHE's ROE of -1.31%. Regarding short-term risk, PIIIW is more volatile compared to RHE. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check RHE's competition here
The Oncology Institute, Inc. (NASDAQ: TOIIW)
PIIIW vs TOIIW Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, TOIIW has a market cap of 4.7M. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while TOIIW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas TOIIW's P/E ratio is -0.17. In terms of profitability, PIIIW's ROE is +1.61%, compared to TOIIW's ROE of +2.10%. Regarding short-term risk, PIIIW is more volatile compared to TOIIW. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check TOIIW's competition here
Starling Oncology Inc. Wt (NASDAQ: STLNW)
PIIIW vs STLNW Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, STLNW has a market cap of 4M. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while STLNW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas STLNW's P/E ratio is -0.13. In terms of profitability, PIIIW's ROE is +1.61%, compared to STLNW's ROE of +2.10%. Regarding short-term risk, PIIIW is less volatile compared to STLNW. This indicates lower risk in terms of short-term price fluctuations for PIIIW.Check STLNW's competition here
IMAC Holdings, Inc. (NASDAQ: IMACW)
PIIIW vs IMACW Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, IMACW has a market cap of 1.7M. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while IMACW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas IMACW's P/E ratio is N/A. In terms of profitability, PIIIW's ROE is +1.61%, compared to IMACW's ROE of +0.73%. Regarding short-term risk, PIIIW is less volatile compared to IMACW. This indicates lower risk in terms of short-term price fluctuations for PIIIW.Check IMACW's competition here
Endovia Health Sciences, Inc. (AMEX: EDVA)
PIIIW vs EDVA Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, EDVA has a market cap of 1.6M. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while EDVA trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas EDVA's P/E ratio is N/A. In terms of profitability, PIIIW's ROE is +1.61%, compared to EDVA's ROE of N/A. Regarding short-term risk, PIIIW is more volatile compared to EDVA. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check EDVA's competition here
EUDA Health Holdings Limited (NASDAQ: EUDAW)
PIIIW vs EUDAW Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, EUDAW has a market cap of 1.1M. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while EUDAW trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas EUDAW's P/E ratio is 0.04. In terms of profitability, PIIIW's ROE is +1.61%, compared to EUDAW's ROE of +1.20%. Regarding short-term risk, PIIIW is more volatile compared to EUDAW. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check EUDAW's competition here
Concord Medical Services Holdings Limited (NYSE: CCM)
PIIIW vs CCM Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, CCM has a market cap of 605.8K. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while CCM trades at $3.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas CCM's P/E ratio is -0.28. In terms of profitability, PIIIW's ROE is +1.61%, compared to CCM's ROE of +0.06%. Regarding short-term risk, PIIIW is more volatile compared to CCM. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check CCM's competition here
NewGenIvf Group Limited (NASDAQ: NIVF)
PIIIW vs NIVF Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, NIVF has a market cap of 72K. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while NIVF trades at $1.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas NIVF's P/E ratio is 0.56. In terms of profitability, PIIIW's ROE is +1.61%, compared to NIVF's ROE of +0.33%. Regarding short-term risk, PIIIW is more volatile compared to NIVF. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check NIVF's competition here
NewGenIvf Group Limited (NASDAQ: NIVFW)
PIIIW vs NIVFW Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, NIVFW has a market cap of 43.2K. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while NIVFW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas NIVFW's P/E ratio is -0.01. In terms of profitability, PIIIW's ROE is +1.61%, compared to NIVFW's ROE of +0.33%. Regarding short-term risk, PIIIW is more volatile compared to NIVFW. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check NIVFW's competition here
Mobile-health Network Solutions Class A Ordinary Shares (NASDAQ: MNDR)
PIIIW vs MNDR Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, MNDR has a market cap of 36.9K. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while MNDR trades at $1.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas MNDR's P/E ratio is -0.04. In terms of profitability, PIIIW's ROE is +1.61%, compared to MNDR's ROE of -0.46%. Regarding short-term risk, PIIIW is more volatile compared to MNDR. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check MNDR's competition here
Talkspace, Inc. (NASDAQ: TALKW)
PIIIW vs TALKW Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, TALKW has a market cap of 33.5K. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while TALKW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas TALKW's P/E ratio is 0.00. In terms of profitability, PIIIW's ROE is +1.61%, compared to TALKW's ROE of +0.00%. Regarding short-term risk, PIIIW is less volatile compared to TALKW. This indicates lower risk in terms of short-term price fluctuations for PIIIW.Check TALKW's competition here
SOC Telemed, Inc. (NASDAQ: TLMDW)
PIIIW vs TLMDW Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, TLMDW has a market cap of 0. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while TLMDW trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas TLMDW's P/E ratio is N/A. In terms of profitability, PIIIW's ROE is +1.61%, compared to TLMDW's ROE of -0.46%. Regarding short-term risk, PIIIW is more volatile compared to TLMDW. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check TLMDW's competition here
Kindred Healthcare, Inc. (NYSE: KND)
PIIIW vs KND Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, KND has a market cap of 0. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while KND trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas KND's P/E ratio is -1.14. In terms of profitability, PIIIW's ROE is +1.61%, compared to KND's ROE of -0.53%. Regarding short-term risk, PIIIW is more volatile compared to KND. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check KND's competition here
Tivity Health, Inc. (NASDAQ: TVTY)
PIIIW vs TVTY Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, TVTY has a market cap of 0. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while TVTY trades at $32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas TVTY's P/E ratio is 19.06. In terms of profitability, PIIIW's ROE is +1.61%, compared to TVTY's ROE of +1.75%. Regarding short-term risk, PIIIW is more volatile compared to TVTY. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check TVTY's competition here
New Frontier Health Corporation (NYSE: NFH)
PIIIW vs NFH Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, NFH has a market cap of 0. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while NFH trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas NFH's P/E ratio is -19.75. In terms of profitability, PIIIW's ROE is +1.61%, compared to NFH's ROE of -0.06%. Regarding short-term risk, PIIIW is more volatile compared to NFH. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check NFH's competition here
Almost Family Inc. (NASDAQ: AFAM)
PIIIW vs AFAM Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, AFAM has a market cap of 0. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while AFAM trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas AFAM's P/E ratio is N/A. In terms of profitability, PIIIW's ROE is +1.61%, compared to AFAM's ROE of +0.06%. Regarding short-term risk, PIIIW is more volatile compared to AFAM. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check AFAM's competition here
SOC Telemed, Inc. (NASDAQ: TLMD)
PIIIW vs TLMD Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, TLMD has a market cap of 0. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while TLMD trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas TLMD's P/E ratio is -1.60. In terms of profitability, PIIIW's ROE is +1.61%, compared to TLMD's ROE of -0.46%. Regarding short-term risk, PIIIW is more volatile compared to TLMD. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check TLMD's competition here
Skylight Health Group Inc. (NASDAQ: SLHG)
PIIIW vs SLHG Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, SLHG has a market cap of 0. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while SLHG trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas SLHG's P/E ratio is -1.48. In terms of profitability, PIIIW's ROE is +1.61%, compared to SLHG's ROE of N/A. Regarding short-term risk, PIIIW is more volatile compared to SLHG. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check SLHG's competition here
DocGo Inc. (NASDAQ: DCGOW)
PIIIW vs DCGOW Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, DCGOW has a market cap of 0. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while DCGOW trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas DCGOW's P/E ratio is N/A. In terms of profitability, PIIIW's ROE is +1.61%, compared to DCGOW's ROE of -1.16%. Regarding short-term risk, PIIIW is more volatile compared to DCGOW. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check DCGOW's competition here
Hanger, Inc. (NYSE: HNGR)
PIIIW vs HNGR Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, HNGR has a market cap of 0. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while HNGR trades at $18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas HNGR's P/E ratio is 19.71. In terms of profitability, PIIIW's ROE is +1.61%, compared to HNGR's ROE of +0.52%. Regarding short-term risk, PIIIW is more volatile compared to HNGR. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check HNGR's competition here
Diversicare Healthcare Services, Inc. (NASDAQ: DVCR)
PIIIW vs DVCR Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, DVCR has a market cap of 0. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while DVCR trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas DVCR's P/E ratio is 28.34. In terms of profitability, PIIIW's ROE is +1.61%, compared to DVCR's ROE of -0.15%. Regarding short-term risk, PIIIW is more volatile compared to DVCR. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check DVCR's competition here
ATI Physical Therapy, Inc. (NYSE: ATIP-WT)
PIIIW vs ATIP-WT Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, ATIP-WT has a market cap of 0. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while ATIP-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas ATIP-WT's P/E ratio is N/A. In terms of profitability, PIIIW's ROE is +1.61%, compared to ATIP-WT's ROE of +2.05%. Regarding short-term risk, PIIIW is more volatile compared to ATIP-WT. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check ATIP-WT's competition here
Skylight Health Group Inc. (NASDAQ: SLHGP)
PIIIW vs SLHGP Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 14.9M. In comparison, SLHGP has a market cap of 0. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while SLHGP trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of N/A, whereas SLHGP's P/E ratio is -30.38. In terms of profitability, PIIIW's ROE is +1.61%, compared to SLHGP's ROE of -0.48%. Regarding short-term risk, PIIIW is more volatile compared to SLHGP. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check SLHGP's competition here